Press Releases
Europe ESR1 Mutated Metastatic Breast Cancer Diagnostics Market Trends and Forecast 2036
NEWARK, Del. — According to Future Market Insights, the global ESR1 mutated metastatic breast cancer diagnostics market is projected to grow from USD 64.61 million
FMI
October 8, 2026